The American Medical Association has called for intensified oversight of the pharmacy benefit manager (PBM) industry; the governor of Florida has signed a bill into law that would allow state residents to access cheaper medication through 2 prescription drug importation programs; the Ebola virus has crossed international borders during the second-worst outbreak in history.
The American Medical Association (AMA) issued a call during its annual meeting for intensified oversight of the pharmacy benefit manager (PBM) industry. According to the AMA, PBMs have similar roles to insurers, yet face no similar oversight, and are hindering policy makers’ efforts to lower drug costs with their “byzantine” confidential contracts that drive increased costs for drugs without justification. The new policy calls for active regulation of PBMs by state departments of insurance and more transparency, according to The Center for Biosimilars®.
Florida Governor Ron DeSantis signed a bill into law yesterday that would allow state residents to access cheaper medication from Canada and other countries through 2 strictly regulated prescription drug importation programs, The New York Times reported. While the legislation must first be approved by the federal government, DeSantis said that President Donald Trump supports the initiative and has directed HHS to accept it. Upon approval, the plan would return to the Florida Legislature for final enactment and funding possibly next year.An Ebola case has been confirmed in Uganda, marking the first time the virus has spread across international borders during the current outbreak, according to The Hill. Aid workers from the US Agency for International Development and the CDC have started vaccinating and training healthcare workers in nations that border affected parts of the Congo, including Uganda, Rwanda, and South Sudan. The outbreak has become the second-worst in recorded history as the virus has infected at least 2062 individuals and caused 1390 deaths.
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Shaping Dermatology's Future by Increasing Access, Data, and Advocacy
March 7th 2025Thy N. Huynh, MD, FAAD, Bruce A. Brod, MHCI, MD, FAAD, and Melissa Piliang, MD, FAAD, discussed expanding access to pediatric dermatology, dermatology data aggregation, and advocacy for Medicare physician payment reform, respectively.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen